David Salisbury

3.9k total citations
60 papers, 2.3k citations indexed

About

David Salisbury is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Salisbury has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Health, 33 papers in Epidemiology and 19 papers in Infectious Diseases. Recurrent topics in David Salisbury's work include Vaccine Coverage and Hesitancy (34 papers), Influenza Virus Research Studies (18 papers) and Pneumonia and Respiratory Infections (13 papers). David Salisbury is often cited by papers focused on Vaccine Coverage and Hesitancy (34 papers), Influenza Virus Research Studies (18 papers) and Pneumonia and Respiratory Infections (13 papers). David Salisbury collaborates with scholars based in United Kingdom, United States and Italy. David Salisbury's co-authors include Mary Ramsay, Elizabeth Miller, Karen Noakes, Joanne Yarwood, Luis Jódar, Dan M. Granoff, Ian M. Feavers, Helen Campbell, Melinda Mills and David E. Bloom and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David Salisbury

58 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Salisbury United Kingdom 22 1.4k 777 746 486 175 60 2.3k
Andrew L. Baughman United States 29 1.8k 1.3× 880 1.1× 504 0.7× 712 1.5× 139 0.8× 57 3.1k
Maria Cristina Rota Italy 28 1.6k 1.2× 396 0.5× 747 1.0× 554 1.1× 147 0.8× 100 2.4k
Hannah Christensen United Kingdom 21 1.5k 1.1× 1.1k 1.5× 406 0.5× 458 0.9× 413 2.4× 74 2.5k
Shelley L. Deeks Canada 33 2.6k 1.8× 750 1.0× 1.2k 1.6× 869 1.8× 310 1.8× 158 3.9k
Deborah Watson‐Jones United Kingdom 30 1.5k 1.1× 307 0.4× 840 1.1× 643 1.3× 114 0.7× 78 2.6k
Fangjun Zhou United States 24 1.9k 1.4× 306 0.4× 814 1.1× 599 1.2× 107 0.6× 56 2.8k
Donatella Panatto Italy 29 1.5k 1.1× 299 0.4× 529 0.7× 667 1.4× 236 1.3× 152 2.7k
Pauline A. Waight United Kingdom 24 3.0k 2.2× 1.1k 1.4× 473 0.6× 341 0.7× 213 1.2× 32 3.5k
Bernard Duval Canada 24 1.4k 1.0× 574 0.7× 531 0.7× 465 1.0× 122 0.7× 85 2.0k
Daniela Amicizia Italy 28 1.3k 0.9× 251 0.3× 426 0.6× 554 1.1× 207 1.2× 112 2.4k

Countries citing papers authored by David Salisbury

Since Specialization
Citations

This map shows the geographic impact of David Salisbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Salisbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Salisbury more than expected).

Fields of papers citing papers by David Salisbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Salisbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Salisbury. The network helps show where David Salisbury may publish in the future.

Co-authorship network of co-authors of David Salisbury

This figure shows the co-authorship network connecting the top 25 collaborators of David Salisbury. A scholar is included among the top collaborators of David Salisbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Salisbury. David Salisbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salisbury, David, Jeffrey V. Lazarus, Nancy M. Waite, et al.. (2024). COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment. JMIR Public Health and Surveillance. 10. e57242–e57242. 2 indexed citations
2.
Lewis, Hannah B, Matthew D. Rousculp, Clara Lehmann, et al.. (2023). MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations. Value in Health. 26(12). S397–S397. 1 indexed citations
3.
Pecetta, Simone, Arindam Nandi, Vanessa Harris, et al.. (2023). Vaccines for a sustainable planet. Science Translational Medicine. 15(685). eadf1093–eadf1093. 7 indexed citations
4.
Bloom, David E., Paolo Bonanni, Federico Martinón‐Torres, et al.. (2023). Meningococcal Disease in the Post–COVID-19 Era: A Time to Prepare. Infectious Diseases and Therapy. 12(12). 2649–2663. 9 indexed citations
5.
Fusco, Manuela Di, Diana Mendes, Lotte Steuten, et al.. (2023). The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines. 11(2). 234–234. 7 indexed citations
6.
Lang, Sarah, et al.. (2019). Two centuries of immunisation in the UK (part II). Archives of Disease in Childhood. 105(3). 216–222. 6 indexed citations
7.
Lang, Sarah, et al.. (2019). Two centuries of immunisation in the UK (part 1). Archives of Disease in Childhood. 105(2). 115–121. 5 indexed citations
8.
Bloom, David E., Steven Black, David Salisbury, & Rino Rappuoli. (2018). Antimicrobial resistance and the role of vaccines. Proceedings of the National Academy of Sciences. 115(51). 12868–12871. 119 indexed citations
9.
Asturias, Edwin J., Melinda Wharton, Robert Pless, et al.. (2016). Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years. Vaccine. 34(29). 3342–3349. 17 indexed citations
10.
Khetsuriani, Nino, et al.. (2014). Simulation Exercises to Strengthen Polio Outbreak Preparedness: Experience of the World Health Organization European Region. The Journal of Infectious Diseases. 210(suppl_1). S208–S215. 8 indexed citations
11.
12.
Campbell, Helen, Ray Borrow, David Salisbury, & Elizabeth Miller. (2009). Meningococcal C conjugate vaccine: The experience in England and Wales. Vaccine. 27. B20–B29. 129 indexed citations
13.
Yarwood, Joanne, et al.. (2007). Tracking mothers’ attitudes to MMR immunisation 1996–2006. Vaccine. 25(20). 3996–4002. 90 indexed citations
14.
Noakes, Karen & David Salisbury. (2006). Immunization Campaigns in the UK. Current topics in microbiology and immunology. 304. 53–70. 6 indexed citations
15.
Yarwood, Joanne, et al.. (2005). Tracking mothers attitudes to childhood immunisation 1991–2001. Vaccine. 23(48-49). 5670–5687. 63 indexed citations
16.
Salisbury, David. (2004). A developing country perspective on vaccine-associated paralytic poliomyelitis. Bulletin of the World Health Organization. 82(1). 57–58. 1 indexed citations
17.
Jódar, Luis, Ian M. Feavers, David Salisbury, & Dan M. Granoff. (2002). Development of vaccines against meningococcal disease. The Lancet. 359(9316). 1499–1508. 201 indexed citations
18.
Salisbury, David. (2001). Introduction of a conjugate meningococcal type C vaccine programme in the UK. Journal of Paediatrics and Child Health. 37(s5). 34–36. 26 indexed citations
19.
Minor, Philip D., Robert Will, & David Salisbury. (2000). Vaccines and variant CJD. Vaccine. 19(4-5). 409–410. 4 indexed citations
20.
Plotkin, Stanley A., et al.. (1998). Preclinical and Clinical Development of New Vaccines. Biologicals. 26(3). 247–251. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew L. Baughman Breakdown of academic impact, for papers by Maria Cristina Rota Breakdown of academic impact, for papers by Hannah Christensen Breakdown of academic impact, for papers by Shelley L. Deeks Breakdown of academic impact, for papers by Deborah Watson‐Jones Breakdown of academic impact, for papers by Fangjun Zhou Breakdown of academic impact, for papers by Donatella Panatto Breakdown of academic impact, for papers by Pauline A. Waight Breakdown of academic impact, for papers by Bernard Duval Breakdown of academic impact, for papers by Daniela Amicizia
Rankless by CCL
2026